In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Shokhrukh A KhasanovSaint Petersburg Pasteur Institute, Federal Service for the Oversight of Consumer Protection and Welfare, 197101 Saint Petersburg, Russia.ORCID 0009-0004-9216-9723 Iana L EsaulkovaSaint Petersburg Pasteur Institute, Federal Service for the Oversight of Consumer Protection and Welfare, 197101 Saint Petersburg, Russia.ORCID 0000-0002-3645-8342 Alexandrina S VolobuevaSaint Petersburg Pasteur Institute, Federal Service for the Oversight of Consumer Protection and Welfare, 197101 Saint Petersburg, Russia.
Alexander V SlitaDivision of Pediatric Infectious Diseases, Rambam Health Care Campus, Haifa 3109601, Israel.
Olga I YarovayaN. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, 630090 Novosibirsk, Russia.ORCID 0000-0002-2333-4893 Anastasia S SokolovaN. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, 630090 Novosibirsk, Russia.
Andrey N GorshkovA. A. Smorodintsev Influenza Research Institute, 197376 Saint Petersburg, Russia.
Anna S DolgovaSaint Petersburg Pasteur Institute, Federal Service for the Oversight of Consumer Protection and Welfare, 197101 Saint Petersburg, Russia.ORCID 0000-0001-8730-4872 Irina N LavrentievaSaint Petersburg Pasteur Institute, Federal Service for the Oversight of Consumer Protection and Welfare, 197101 Saint Petersburg, Russia.
Vladimir G DedkovSaint Petersburg Pasteur Institute, Federal Service for the Oversight of Consumer Protection and Welfare, 197101 Saint Petersburg, Russia.ORCID 0000-0002-5500-0169 Nariman F SalakhutdinovN. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, 630090 Novosibirsk, Russia.
Vladimir V ZarubaevSaint Petersburg Pasteur Institute, Federal Service for the Oversight of Consumer Protection and Welfare, 197101 Saint Petersburg, Russia.ORCID 0000-0002-5224-3771 Funding
Ministry of Science and Higher Education of the Russian Federation FWUE-2025-0006Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) 121030200272-6
6 · The paper itselfAbstract
Requirements for novel effective antiviral agents against SARS-CoV-2 emphasizes the importance of robust in vitro screening platforms. We developed a test system based on spike-pseudotyped lentiviruses, carrying either
Indexed as
Antiviral AgentsSARS-CoV-2Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Cell Line, TumorCOVID-19COVID-19 Drug TreatmentDrug Evaluation, PreclinicalHumansLentivirusViral PseudotypingACE2 protein, humanAngiotensin-Converting Enzyme 2Antiviral AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ACE2antiviralscoronavirusH1299lentiviruspseudotypingSARS-CoV-2spike protein
Identifiers
PMID41596439
PMCPMC12841467
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390